{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-007754","form_type":"8-K","ticker":"SDEV","cik":"0001389545","company_name":"Stablecoin Development Corp","filed_at":"2024-03-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.024679+00:00","generated_at":"2026-06-04T19:08:09.521012+00:00","sec_items":["1.01","2.02","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NovaBay sells DERMAdoctor skincare for $1.07M; reports Q4 net sales $3.7M, operating loss $3.2M","bullets":["Sells DERMAdoctor for ~$1.07M cash to New Age Investments; closing expected by March 31, 2024.","Q4 2023 net sales $3.7M (DERMAdoctor $0.9M, eyecare/wound care $2.8M); operating loss $3.2M.","FY 2023 net sales $14.7M, operating loss $7.4M including $2.5M non-cash impairment of DERMAdoctor assets.","CEO says sale reduces operating expenses and provides cash to focus on core Avenova business and Eyenovia partnership.","Cash as of Dec 31, 2023 was $3.1M; convertible notes $1.1M net."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-007754","json":"https://secwatch.observer/filing/0001437749-24-007754.json","markdown":"https://secwatch.observer/filing/0001437749-24-007754.md","text":"https://secwatch.observer/filing/0001437749-24-007754.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1389545/000143774924007754/0001437749-24-007754-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1389545/000143774924007754/nby20240313_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T19:08:09.521012+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7275c14cb07e8ea3c1998ff586579a12d83e8059","claim":"Stablecoin Development Corp reported preliminary financial results for three and twelve months ended December 31, 2023.","evidence_excerpt":"On March 14, 2024, the Company issued a press release announcing that it had entered into the Purchase Agreement and regarding its results for the three and twelve months ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774924007754/0001437749-24-007754-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and twelve months ended December 31, 2023"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"c7f95024a0ce8f6dd6e188db9b8aa8a88f9a0644","claim":"Stablecoin Development Corp entered into Membership Unit Purchase Agreement with New Age Investments LLC valued at $1,070,000 (effective 2024-03-12).","evidence_excerpt":"On March 12, 2024, NovaBay Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), entered into a Membership Unit Purchase Agreement (the “ Purchase Agreement ”) by and among: (i) New Age Investments LLC, a Florida limited liability company (the “ Buyer ”); (ii) DERMAdoctor, LLC, a Missouri limited liability company (“ DERMAdoctor ”); and (iii) the Company.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1389545/000143774924007754/0001437749-24-007754-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"New Age Investments LLC"},{"label":"Value","value":"$1,070,000"},{"label":"Effective","value":"2024-03-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}